ENANTA PHARMACEUTICALS, INC (ENTA) Total liabilities 2017–2025
ENANTA PHARMACEUTICALS, INC (ENTA) total liabilities at each fiscal year-end, per SEC filings.
$216.0MFY2025 · since FY2017: $25.0M → $216.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $216.0M | -12.8% |
| FY2024 | $247.8M | +0.9% |
| FY2023 | $245.5M | +354.1% |
| FY2022 | $54.1M | +37.4% |
| FY2021 | $39.4M | +28.8% |
| FY2020 | $30.6M | +11.8% |
| FY2019 | $27.3M | +33.0% |
| FY2018 | $20.5M | -17.7% |
| FY2017 | $25.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice